You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

Drug Price Trends for LORATADINE ALLERGY


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for LORATADINE ALLERGY

Average Pharmacy Cost for LORATADINE ALLERGY

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LORATADINE ALLERGY 5 MG/5 ML 54838-0558-40 0.04133 ML 2025-03-19
LORATADINE ALLERGY 5 MG/5 ML 54838-0558-40 0.04165 ML 2025-02-19
LORATADINE ALLERGY 5 MG/5 ML 54838-0558-40 0.03906 ML 2025-01-22
LORATADINE ALLERGY 5 MG/5 ML 54838-0558-40 0.03842 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Loratadine Market Analysis and Price Projections

Market Overview

The loratadine market is a significant sector within the pharmaceutical industry, driven by the increasing prevalence of allergic conditions globally. Here are the key points that define the current and future landscape of the loratadine market.

Market Size and Growth

As of 2023, the global loratadine market was valued at approximately USD 153.4 million[1][4][5].

  • The market is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030[1].
  • Alternative forecasts suggest a CAGR of 2.8% between 2024 and 2032[4] and 3.14% from 2024 to 2029[5].

Drivers of Market Growth

Increasing Prevalence of Allergies

The global prevalence of allergic rhinitis is estimated to be between 10% and 30% worldwide, affecting approximately 400 million people globally[1][4].

  • This high prevalence rate, coupled with the effectiveness of loratadine in relieving symptoms such as sneezing, itching, and runny nose, fuels market growth.

Changing Lifestyles and Environmental Factors

Changes in lifestyles and exposure to allergens like dust mites and pet dander have increased the number of indoor allergies, contributing positively to product demand[1].

Regulatory Landscape and Awareness

A favorable regulatory landscape and heightened awareness regarding respiratory health and allergy management are significant drivers of the market[1][4].

Impact of COVID-19

The COVID-19 pandemic moderately impacted the market, with increased focus on respiratory health and studies examining the potential effectiveness of loratadine in treating COVID-related symptoms[1][3].

Regional Analysis

North America

North America dominated the market share in 2023, driven by a high disease burden and the strong presence of several manufacturers[1][5].

  • The region is expected to experience substantial growth due to its robust healthcare infrastructure, high allergy prevalence, and active market players[3].

Asia Pacific

The Asia Pacific region is predicted to witness the fastest CAGR over the forecast period. This growth is attributed to:

  • Rapidly growing awareness regarding allergic ailments.
  • A rising geriatric population prone to allergic conditions.
  • Increasing prevalence of lifestyle diseases[1].

Product Forms and Pricing

Forms of Loratadine

Loratadine is available in various forms, including:

  • Oral tablets.
  • Oral syrup.
  • Chewable tablets.
  • Disintegrating tablets[2][4].

Pricing

The cost of loratadine varies based on the form and quantity:

  • A supply of 10 loratadine 10 mg oral tablets can cost around $10[2].
  • Loratadine oral syrup (5 mg/5 mL) can cost from $12.45 for 118 milliliters[2].
  • Chewable tablets (5 mg) can cost from $26.84 for 30 tablets[2].

Market Challenges

Side Effects and Tolerance

Despite its general well-tolerance, loratadine may be associated with side effects such as headache, dry mouth, fatigue, or gastrointestinal disturbances. The development of tolerance over prolonged use is also a challenge, potentially leading to higher doses for continued efficacy[5].

Key Players and Market Competition

The global loratadine market is highly competitive, with key players focusing on product innovation and geographical expansion. Companies like Bayer AG, Pfizer Inc., and others continue to explore new applications and formulations of loratadine[3].

Future Outlook

Ongoing Research and Development

Continuous development in loratadine drugs, including ongoing clinical trials and regulatory approvals, is projected to drive the growth of the market. The potential effectiveness of loratadine in treating COVID-related symptoms has also been a subject of study, further boosting its market potential[1][3].

Consumer Preference

The growing awareness among patients regarding the over-the-counter (OTC) availability and benefits of loratadine, particularly its non-drowsy formulations, is expected to spur regional revenue growth[1][4].

"Loratadine, a second-generation antihistamine, is renowned for its efficacy in alleviating symptoms associated with allergies, such as hay fever, allergic rhinitis, and urticaria"[5].

Key Takeaways

  • The loratadine market is expected to grow steadily, driven by the increasing prevalence of allergic conditions and favorable regulatory landscapes.
  • North America and the Asia Pacific region are key markets, with North America dominating the current market share and the Asia Pacific region expected to grow the fastest.
  • The availability of loratadine in various forms and its non-drowsy nature contribute to its market growth.
  • Despite potential side effects and the development of tolerance, the market is poised for sustained growth due to ongoing research and development.

FAQs

What is the current market size of the loratadine market?

The global loratadine market was valued at approximately USD 153.4 million in 2023[1].

What is the expected CAGR of the loratadine market?

The market is expected to grow at a CAGR of 2.9% from 2024 to 2030, though other forecasts suggest a CAGR of 2.8% between 2024 and 2032 and 3.14% from 2024 to 2029[1][4][5].

Which region dominates the loratadine market?

North America dominated the market share in 2023 due to its robust healthcare infrastructure and high allergy prevalence[1][5].

What are the main drivers of the loratadine market growth?

The main drivers include the increasing prevalence of allergic conditions, changing lifestyles, favorable regulatory landscapes, and the impact of the COVID-19 pandemic[1][3][4].

What are the common forms of loratadine available in the market?

Loratadine is available in oral tablets, oral syrup, chewable tablets, and disintegrating tablets[2][4].

Sources

  1. Grand View Research - Loratadine Market Size, Share, Growth, Trends Report, 2030
  2. Drugs.com - Loratadine Prices, Coupons, Copay Cards & Patient Assistance
  3. Mordor Intelligence - Global Loratadine Market Size - Mordor Intelligence
  4. GMI Insights - Loratadine Market Size, Share & Growth Report, 2024 – 2032
  5. TechSci Research - Loratadine Market By Size, Share and Forecast 2029F

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.